Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario Serio

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Molecular Genetics|January 8, 2010
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxinIvano Condò, Florence Malisan, Ilaria Guccini, et al.
Human Molecular Genetics|January 11, 2011
Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxiaAlessandra Rufini, Silvia Fortuni, Gaetano Arcuri, et al.
Cell Reports|February 24, 2017
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich AtaxiaMonica Benini, Silvia Fortuni, Ivano Condò, et al.
Human Molecular Genetics|May 8, 2015
Src inhibitors modulate frataxin protein levelsFabio Cherubini, Dario Serio, Ilaria Guccini, et al.
Neurobiology of Disease|January 1, 2015
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cellsAlessandra Rufini, Francesca Cavallo, Ivano Condò, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 10, 2019
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxiaGiulia Alfedi, Riccardo Luffarelli, Ivano Condò, et al.
Human Molecular Genetics|January 17, 2020
Frataxin deficiency in Friedreich's ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survivalFrancesca Tiano, Francesca Amati, Fabio Cherubini, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Molecular Genetics|January 8, 2010
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxinIvano Condò, Florence Malisan, Ilaria Guccini, et al.
Human Molecular Genetics|January 11, 2011
Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxiaAlessandra Rufini, Silvia Fortuni, Gaetano Arcuri, et al.
Cell Reports|February 24, 2017
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich AtaxiaMonica Benini, Silvia Fortuni, Ivano Condò, et al.
Human Molecular Genetics|May 8, 2015
Src inhibitors modulate frataxin protein levelsFabio Cherubini, Dario Serio, Ilaria Guccini, et al.
Neurobiology of Disease|January 1, 2015
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cellsAlessandra Rufini, Francesca Cavallo, Ivano Condò, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 10, 2019
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxiaGiulia Alfedi, Riccardo Luffarelli, Ivano Condò, et al.
Human Molecular Genetics|January 17, 2020
Frataxin deficiency in Friedreich's ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survivalFrancesca Tiano, Francesca Amati, Fabio Cherubini, et al.
Pageof 1